Richard Horton, who are in Lancet, who still runs it, says the same thing at the, you know, the journals. And those are the people running them. What happens? They make huge amounts of money from advertising, which is paid for [by] pharmaceutical companies. And through a scheme called preprints where the pharmaceutical company plans a story, they pay for the journal about a drug that they're trying to promote. (29:16–29:23)
CLAIM
Asserts that medical journals profit significantly from pharmaceutical company advertising.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
